iPSC-Derived Immunotherapies Congress 2022

iPSC-Derived Immunotherapies Congress

View Agenda
Boston, MA, USA
18-19 October, 2022

Enabling safe, genome stable iPSC-derived cell therapies through ex-vivo gene editing, efficient feeder system enabled differentiation and regulatory compliant product characterization to drive clinical progression.

Why Attend

iPSCs show great promise in addressing the current challenges surrounding cost and demand associated with current cell therapies on the market, but with genomic stability concerns and manufacturing complexities, these therapies are still at early stages of clinical progression. This event will highlight techniques used to develop safe, differentiated and efficacious therapies to pass through regulatory hurdles. Explore key techniques focused on addressing issues in teratoma formation, genomic instability, off-target modifications, ex vivo gene editing to target immunogenicity, and feeder system complexity. This event is your opportunity to analyze developments in bringing iPSC-derived immunotherapies from bench to bedside to deliver long-lasting, safe, effective therapeutics.

Who will be there

Biotechnology

  • C-Suite
  • Senior/ Principal Scientist
  • Dir/ SVP Pharmacovigilance
  • Dir/ SVP Manufacturing
  • Dir/ SVP Medical Affairs
  • Dir/ SVP Translational Medicine
  • Dir/ SVP Quality Control

Pharmaceutical

With a responsibility for Cell Therapy/ Oncology

  • Scientific Officer
  • Lead Scientist
  • Dir/ SVP Pharmacovigilance
  • Dir/ SVP Manufacturing
  • Dir/ SVP Medical Affairs
  • Dir/ SVP Translational Medicine

Service Providers

  • Research and Development
  • Stem Cell Services/ Director
  • Technical Product Manager
  • Head of Business, Stem Cells
  • Research Services
  • Cell Type Development
  • Clinical Translation
  • Manufacturing Development
  • Process Engineering
  • Business Development – Stem Cells
  • iPSC lead
  • Quality Assurance
  • Clinical Manufacturing
  • Quality Control

Academia/ Research Institutes

Professor/ Researcher/ Investigator

  • Biomedical Sciences
  • Clinical Medicine
  • Immunology
  • Immuno-oncology
  • Immunotherapy
  • Biomedical Engineering
  • Molecular/Cellular Biotechnology
  • Stem Cell

Past Attendees to the Cell Therapy Congress Series

Speakers

 

Stefan Frank

Associate Director iPSC Platform Strategy
Bayer

Stefan Frank

Associate Director iPSC Platform Strategy
Bayer

Stefan Frank

Associate Director iPSC Platform Strategy
Bayer
 

Kevin D’Amour

CSO
Brooklyn ImmunoTherapeutics

Kevin D’Amour

CSO
Brooklyn ImmunoTherapeutics

Kevin D’Amour

CSO
Brooklyn ImmunoTherapeutics
 

Nicholas Boyd

Chief Development Officer
Cartherics

Nicholas Boyd

Chief Development Officer
Cartherics

Nicholas Boyd

Chief Development Officer
Cartherics
 

Jay Mills

Director of Process Development
Century Therapeutics

Jay Mills

Director of Process Development
Century Therapeutics

Jay Mills

Director of Process Development
Century Therapeutics
 

Gregory Fiore

CEO
Exacis Biosciences

Gregory Fiore

CEO
Exacis Biosciences

Gregory Fiore

CEO
Exacis Biosciences
 

Mark Plavsic

Chief Technical Officer
Fate Therapeutics

Mark Plavsic

Chief Technical Officer
Fate Therapeutics

Mark Plavsic

Chief Technical Officer
Fate Therapeutics
 

Mania Ackermann

Professor
Hannover Medical School

Mania Ackermann

Professor
Hannover Medical School

Mania Ackermann

Professor
Hannover Medical School
 

Allen Feng

CEO
HebeCell

Allen Feng

CEO
HebeCell

Allen Feng

CEO
HebeCell
 

Kimberly Schluns

Senior Director
Research, Kite Pharma

Kimberly Schluns

Senior Director
Research, Kite Pharma

Kimberly Schluns

Senior Director
Research, Kite Pharma
 

Yuguo (Leo) Lei

Associate Professor
Penn State

Yuguo (Leo) Lei

Associate Professor
Penn State

Yuguo (Leo) Lei

Associate Professor
Penn State
 

Alex Armesilla

Director – Cell Engineering
Resolution Therapeutics

Alex Armesilla

Director – Cell Engineering
Resolution Therapeutics

Alex Armesilla

Director – Cell Engineering
Resolution Therapeutics
 

Sonja Schrepfer

Scientific Founder and SVP
Sana Biotechnology

Sonja Schrepfer

Scientific Founder and SVP
Sana Biotechnology

Sonja Schrepfer

Scientific Founder and SVP
Sana Biotechnology
 

Lan Cao

VP, Head of Cell Therapy Innovation Group
Takeda

Lan Cao

VP, Head of Cell Therapy Innovation Group
Takeda

Lan Cao

VP, Head of Cell Therapy Innovation Group
Takeda
 

David Vereide

iPSC Lead
Umoja Biopharma

David Vereide

iPSC Lead
Umoja Biopharma

David Vereide

iPSC Lead
Umoja Biopharma
 

Tom Schulz

Head iPSC CAR Development
Allogene Therapeutics

Tom Schulz

Head iPSC CAR Development
Allogene Therapeutics

Tom Schulz

Head iPSC CAR Development
Allogene Therapeutics
 

Nico Lachmann

Principle Investigator
Hannover Medical School

Nico Lachmann

Principle Investigator
Hannover Medical School

Nico Lachmann

Principle Investigator
Hannover Medical School
 

Huang Zhu

Senior Director, Cell Therapy R&D
Shoreline Biosciences

Huang Zhu

Senior Director, Cell Therapy R&D
Shoreline Biosciences

Huang Zhu

Senior Director, Cell Therapy R&D
Shoreline Biosciences
 

Michael Nehil

Associate Director
Editas Medicine

Michael Nehil

Associate Director
Editas Medicine

Michael Nehil

Associate Director
Editas Medicine
 

Robert Brooks

CEO
Alphageneron

Robert Brooks

CEO
Alphageneron

Robert Brooks

CEO
Alphageneron
 

Daniel Teper

CEO
Cytovia

Daniel Teper

CEO
Cytovia

Daniel Teper

CEO
Cytovia
 

Jiwu Wang

Founder and CEO
Allele Biotech

Jiwu Wang

Founder and CEO
Allele Biotech

Jiwu Wang

Founder and CEO
Allele Biotech

Sponsors

Exhibitors

Event Partners

Media Partners

Download the agenda

Please fill in your details to receive the agenda.

Download Full Agenda

Venue

Venue

Hilton Boston Back Bay Hotel, 40 Dalton St, Boston, MA 02115, USA

   

Register Your Place

Sending Your Team? Group Discounts Available!

Applicable for Primary Market, Service Provider and Industry Rates Only. Not available for Academic or ‘Start-Up’ rates

Book a Team of 3+ - Save an Additional 10% Off
Book a Team of 5+ - Save an Additional 15% Off

If you would like to register a team of 3 or more, please email [email protected] for your discount coupon code before registering. PLEASE NOTE: Discounts cannot be combined with Early Bird Pricing or any other discount or offer. If you have any questions about your registration, please call us on +44 (0)20 3696 2920

We accept the following cards through Stripe:

Registration ends in

Saturday, September 24, 2022 to Tuesday, October 18, 2022
Tier 1 - Academics (a teacher or scholar in a university or other institute of higher education)
$1,299.00
Standard
Saturday, September 24, 2022 to Tuesday, October 18, 2022
Tier 2 - Biotech & Pharma (Companies with a cell therapy product development pipeline)
$2,399.00
Standard
Saturday, September 24, 2022 to Tuesday, October 18, 2022
Tier 3 - Industry/ Service Provider (Companies providing a service, product or technology)
$3,499.00
Standard
Preparing registration...

Resources

Download Resource

Contact Us